Vera B Morhenn

US Patent:

40318869, Jun 28, 1977

Filed:

Aug 30, 1976

Appl. No.:

5/718614

Inventors:

Vera B. Morhenn - Palo Alto CA

International Classification:

A61F 524

US Classification:

128130

Abstract:

A pessary is described which not only serves to support and protect the position of the uterus but is also occlusive in order to enable the local application of medication and to achieve contraception. The specific shape of the pessary in order to provide ease in handling and application is disclosed. Embodiments preferred for hygienic reasons and for the timed application of medications are described.

US Patent:

48867454, Dec 12, 1989

Filed:

Mar 30, 1984

Appl. No.:

6/595075

Inventors:

Vera Morhenn - Palo Alto CA

Assignee:

Syntex Inc. - Palo Alto CA

International Classification:

G01N 33577

US Classification:

435 7

Abstract:

The present invention is concerned with novel monoclonal antibodies specific for an antigenic site on a protein characteristic of a human basal cell and a malignant squamous cell. The antibodies do not bind to mesenchymal cells such as fibroblasts and endothelial cells. The protein on the cell surface which binds to one of the antibodies has a molecular weight of about 120,000 as determined by one dimensional gel electrophoresis. The antibodies find use in diagnostic methods such as the detection of malignant cells, e. g. , the detection of residual tumor cells in skin subjected to microscopically-controlled surgery.

US Patent:

47820152, Nov 1, 1988

Filed:

Mar 30, 1984

Appl. No.:

6/595073

Inventors:

Anthony C. Allison - Belmont CA
Vera Morhenn - Palo Alto CA
Alain B. Schreiber - Mountain View CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

G01N 33577

US Classification:

435 7

Abstract:

The present invention is concerned with a method for determining the presence of a malignant condition at a locus of interest. An exfoliative cell specimen obtained from the locus is contacted with an antibody specific for an antigenic site that is usually only found in the specimen when a malignant condition is present. The contact is made under conditions for detectable binding of the antibody to such antigenic site. After contact, the presence of binding of the antibody to the antigenic site is observed. The binding of the antibody is related to the presence of a malignant condition at the locus. The invention finds utility, for example, in the detection of cervical carcinoma.

US Patent:

20190223848, Jul 25, 2019

Filed:

Jan 23, 2018

Appl. No.:

15/877456

Inventors:

Harvey Fishman - Menlo Park CA, US
Vera B. Morhenn - Woodside CA, US
Jonathan N. Mansbridge - Woodside CA, US

International Classification:

A61B 10/02
A61B 3/00
A61B 3/14

Abstract:

The biological material gathering device disclosed herein is designed for non-invasive isolation of biological material from an eye, eyelid, or periocular. The device uses a plurality of adhesive beads engaged on a microfiber bundle to harvest biological materials from an individual without the need for penetrating or invasive methods. Such biological materials may then be processed and examined to determine the etiology of pathologies or malignancies affecting the individual. The biological material gathering device preferably comprises a tonometer tip base and housing for use in commonly-available ophthalmological examination devices. The present invention may further comprise video imaging capability so as to register the precise and relative locations of harvested biological materials for later reference. Finally, the biological material gathering device disclosed herein may be made available in kit form for clinical use.